phenylephrine has been researched along with Diabetic Glomerulosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T; Honda, K; Kasono, K; Nobe, K; Takenouchi, Y | 1 |
| Abdulla, MH; Abdullah, NA; Basri, F; Dewa, A; Hussain, NM; Johns, EJ; Kazi, RN; Khan, MA; Rathore, HA; Salman, IM; Sattar, MA; Swarup, KR | 1 |
| Arellano-Mendoza, MG; Castorena-Torres, F; Coronel, I; del Valle-Mondragon, L; Escalante, B; Rios, A; Romo, E; Vargas-Robles, H | 1 |
| Falcone, JC; Fleming, JT; Joshua, IG; Passmore, JC; Rodriguez, WE; Tyagi, N; Tyagi, SC | 1 |
4 other study(ies) available for phenylephrine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Two types of overcontraction are involved in intrarenal artery dysfunction in type II diabetic mouse.
Topics: Acetophenones; Animals; Benzopyrans; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Male; Mice; Mice, Obese; Phenylephrine; Protein Kinase C; Protein Kinase Inhibitors; Renal Artery; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents | 2014 |
Functional subtypes of renal alpha1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy.
Topics: Adrenergic Antagonists; Amlodipine; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Electric Stimulation; Hypertension; Kidney; Male; Methoxamine; Norepinephrine; Phenylephrine; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Streptozocin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Enzyme Inhibitors; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vitamin E | 2010 |
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
Topics: Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fats; Hemodynamics; Homocysteine; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phenylephrine; Pioglitazone; Thiazolidinediones | 2006 |